Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk

The move limits the vaccine to individuals 18 and older for whom other other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as those 18 and older who would otherwise not receive a COVID-19 vaccine.

The USPSTF changed the low-dose aspirin recommendations for cardiovascular disease prevention in April 2022 by suggesting patients over age 60 without history of CVD should not take it and people 40-60 should only take it if there are other risk factors.

VIDEO: USPSTF official discusses new low-dose aspirin recommendations

Michael J. Barry, MD, vice chair of the U.S. Preventive Services Task Force, gave Cardiovascular Business an overview of the new recommendations.

transcatheter aortic valve replacement (TAVR) procedure guided by CT fusion imaging on a patient with heart failure and a blood clot

Cardiologists and surgeons perform first TAVR using CT imaging guidance on HF patient with blood clot

“We believe this case is potentially groundbreaking," one interventional cardiologist said. 

The steps involved to gain transcaval access between the inferior vena cava and the aorta to avoid problematic anatomical areas that would have otherwise disqualified a patient for a femoral access TAVR procedure. Illustration of the NIH

Transcaval TAVR outperforms transaxillary TAVR when femoral access is not an option

Transcaval TAVR was linked to a much lower stroke rate and fewer bleeding complications. 

Thumbnail

Combining certain BP medications with NSAIDs linked to kidney damage—acetaminophen seen as a safer option

A team of researchers used computer science and mathematics to study the "triple whammy" of diuretics, RAS inhibitors and NSAIDs.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

VIDEO: Shockwave Medical demonstrates faster intravascular lithotripsy at ACC.22

The new Shockwave Medical M5+ peripheral intravascular lithotripsy (IVL) catheter made its debut at ACC.22. 

Thumbnail

How the science behind COVID-19 vaccines could transform care for heart attack patients

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

Thumbnail

Unpaid student loan debt is bad for the heart

An American Journal of Preventive Medicine study highlights higher rates of cardiovascular disease for adults who fail to pay down student debt.

Displaying 1689 - 1696 of 10742

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.